Treatment for infection with hepatitis b virus alone or in combination with hepatitis delta virus and associated liver diseases
AssigneeNovartis AG
InventorNikolai Naoumov
Life of this patent
Estimating the term…
Abstract
The invention concerns the use of cyclophilin inhibitors in the treatment of Hepatitis B and Hepatitis D virus infections.
Claims6
Alisporivir for use in the treatment of Hepatitis B virus infection and Hepatitis D virus infection in a patient.
A method for treating a Hepatitis B virus infection in a patient comprising administering an effective amount of alisporivir and optionally administering to the patient an interferon or a direct antiviral agent.
A method for treating a Hepatitis Delta virus infected infection in a patient comprising administering an effective amount of alisporivir and optionally administering to the patient an interferon or a direct antiviral agent.
A method for prevention of progression of liver disease in a patient comprising administering alisporivir.
Dependencies are inferred from the claim text.